About CorisBio
CorisBio is a company based in Gembloux (Belgium) founded in 1996 was acquired by Avacta in June 2023. CorisBio offers products and services including BL-RED, OXA-48 K-SeT, RESIST-5, Crypto/Giardia Duo-Strip, and Influ A+B K-SeT. CorisBio operates in a competitive market with competitors including OpGen, Avails Medical, Resistell, NOWDiagnostics and HandyLab, among others.
- Headquarter Gembloux, Belgium
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CorisBio
CorisBio offers a comprehensive portfolio of products and services, including BL-RED, OXA-48 K-SeT, RESIST-5, Crypto/Giardia Duo-Strip, and Influ A+B K-SeT.
Detects beta lactamases via electrochemistry technology
Identifies OXA-48-like carbapenemases using lateral flow
Tests for KPC, NDM, VIM, IMP carbapenemases
Detects Cryptosporidium and Giardia parasites
Identifies Influenza A and B viruses via lateral flow
Funding Insights of CorisBio
Investors in CorisBio
CorisBio has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Avacta and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Developer of therapeutics and diagnostics for the treatment of cancer
|
Locked | Locked | Locked |
Investor details for CorisBio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CorisBio
Investment portfolio details for CorisBio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CorisBio
Detailed financials for CorisBio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Corisbio Comparisons
Peer comparison for CorisBio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CorisBio
CorisBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as OpGen, Avails Medical, Resistell, NOWDiagnostics and HandyLab, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of diagnostics and bioinformatics platforms for providers
|
|
| Locked | Locked | Locked |
Point-of-care devices are developed for infection diagnosis and treatment optimization.
|
|
| Locked | Locked | Locked |
Antibiotic susceptibility testing is provided via bacterial movement detection.
|
|
| Locked | Locked | Locked |
Develops rapid assay medical tests that use a single drop of blood to test for a variety of common conditions, illnesses and diseases
|
|
| Locked | Locked | Locked |
Molecular diagnostic assays and automation platforms are developed.
|
|
| Locked | Locked | Locked |
Instruments and assays for molecular pathogen detection are developed.
|
Detailed competitors of CorisBio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Corisbio
Complete news archive for CorisBio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CorisBio
CorisBio was founded in 1996 and raised its 1st funding round 19 years after it was founded.
CorisBio is headquartered in Gembloux, Belgium. It is registered at Gembloux, Namur, Belgium.
Coris BioConcept is engaged in the development, production and commercialization of rapid diagnostic tests for the detection of the pathogen for enteric, gastric and respiratory diseases. The company utilizes immunochromatography technology with colloidal gold particles or latex microspheres to develop their products. The tests are available in two formats: dipstick and cassette. The company also offers tests under the brand name RESIST for the detection of antibiotic-resistant bacteria. The company offers products in more than 70 countries in Europe, Asia, South America, Africa, Oceania, Ireland, United Kingdom, and Norway. It is among the leaders on the Belgian market (80).
CorisBio's top competitors include Avails Medical, OpGen and Verax Biomedical.
CorisBio offers BL-RED, OXA-48 K-SeT, RESIST-5, Crypto/Giardia Duo-Strip, and Influ A+B K-SeT.
CorisBio has 2 investors. Key investors include Avacta, and European Union.